ATP-citrate synthase (ACLY) Antibody

Este producto es parte de ACLY - ATP-Citrate Synthase
ATP-citrate synthase (ACLY) Antibody
299€ (50 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
ATP-citrate synthase (ACLY) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx402375
Tested Applications
ELISA, WB, IF/ICC, FCM

Description

ATP-citrate synthase (ACLY) Antibody is a Recombinant Rabbit Monoclonal antibody for the detection of Human ACLY.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: ATP-citrate synthase (ACLY)
Immunogen: A synthesized peptide derived from human ATP citrate lyase
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 1/500 - 1/5000, IF/ICC: 1/20 - 1/200, FCM: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG
Expression
Recombinant
Purification
Purified by affinity chromatography.
Size 1
50 µl
Size 2
100 µl
Form
Liquid
Tested Applications
ELISA, WB, IF/ICC, FCM
Buffer
PBS, pH 7.4, 150 mM NaCl, 0.02% sodium azide and 50% glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P53396
Gene ID
47
OMIM
108728
Alias
ACL,ATPCL,CLATP
Background
Antibody anti-ACLY
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

ATP-Citrate Synthase (ACLY) is a cytoplasmic enzyme that catalyzes the conversion of citrate and CoA into acetyl-CoA and oxaloacetate, a reaction powered by ATP hydrolysis. ACLY is a central player in cellular metabolism, linking energy production in the mitochondria with fatty acid and cholesterol biosynthesis. Acetyl-CoA generated by ACLY serves as a precursor for lipid synthesis and is essential for protein acetylation, including histone acetylation, which regulates gene expression. ACLY activity is upregulated in cancer cells to support rapid cell proliferation and metabolic reprogramming, making it a target for cancer therapy. Dysregulation of ACLY is also associated with metabolic diseases such as obesity, insulin resistance, and hyperlipidemia.

Productos relacionados

abx010428

ATP-Citrate Synthase (ACLY) Antibody

ATP citrate lyase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. The enzym…

Ver producto
abx111118

ATP-Citrate Synthase (ACLY) Antibody

Atp Citrate Lyase Antibody is a Rabbit Polyclonal antibody against Atp Citrate Lyase.…

Ver producto
abx122800

ATP-Citrate Synthase (ACLY) Antibody

Rabbit Polyclonal against the ACLY protein.…

Ver producto